Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction. [electronic resource]
Producer: 20090226Description: 81-5 p. digitalISSN:- 1473-5830
- Administration, Oral
- Aged
- Brachial Artery -- drug effects
- Capsules
- Chemistry, Pharmaceutical
- Cross-Over Studies
- Delayed-Action Preparations
- Dietary Fats -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Endothelium, Vascular -- diagnostic imaging
- Fatty Acids, Monounsaturated -- administration & dosage
- Female
- Fluvastatin
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hyperlipidemias -- blood
- Indoles -- administration & dosage
- Male
- Metabolic Syndrome -- diagnostic imaging
- Middle Aged
- Postprandial Period
- Regional Blood Flow
- Tablets
- Time Factors
- Treatment Outcome
- Triglycerides -- blood
- Ultrasonography
- Vasodilation -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.